Correlation Between 10X Genomics and Veracyte
Can any of the company-specific risk be diversified away by investing in both 10X Genomics and Veracyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and Veracyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 10X Genomics and Veracyte, you can compare the effects of market volatilities on 10X Genomics and Veracyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of Veracyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and Veracyte.
Diversification Opportunities for 10X Genomics and Veracyte
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between 10X and Veracyte is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and Veracyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veracyte and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with Veracyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veracyte has no effect on the direction of 10X Genomics i.e., 10X Genomics and Veracyte go up and down completely randomly.
Pair Corralation between 10X Genomics and Veracyte
Considering the 90-day investment horizon 10X Genomics is expected to under-perform the Veracyte. In addition to that, 10X Genomics is 1.28 times more volatile than Veracyte. It trades about -0.03 of its total potential returns per unit of risk. Veracyte is currently generating about 0.17 per unit of volatility. If you would invest 3,498 in Veracyte on November 2, 2024 and sell it today you would earn a total of 1,116 from holding Veracyte or generate 31.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
10X Genomics vs. Veracyte
Performance |
| Timeline |
| 10X Genomics |
| Veracyte |
10X Genomics and Veracyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 10X Genomics and Veracyte
The main advantage of trading using opposite 10X Genomics and Veracyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, Veracyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veracyte will offset losses from the drop in Veracyte's long position.| 10X Genomics vs. Twist Bioscience Corp | 10X Genomics vs. Fate Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Veracyte |
| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges |